OTCMKTS:ENZN - Enzon Pharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.2210 0.00 (0.00 %)
(As of 12/9/2018 03:17 PM ET)
Previous Close$0.2210
Today's Range$0.22 - $0.2250
52-Week Range$0.2040 - $0.32
Volume10,198 shs
Average Volume73,506 shs
Market Capitalization$9.77 million
P/E RatioN/A
Dividend YieldN/A
Beta0.7
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in licensing drug products. Its marketed drug products include PegIntron for use in the treatment of chronic hepatitis C; and Sylatron for use in the treatment of melanoma disease. The company was founded in 1981 and is headquartered in Cranford, New Jersey.

Receive ENZN News and Ratings via Email

Sign-up to receive the latest news and ratings for ENZN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Biological products, except diagnostic
Sub-IndustryBiotechnology
SectorMedical
Current SymbolOTCMKTS:ENZN
Previous SymbolNASDAQ:ENZN
CUSIP29390410
Phone732-980-4500

Debt

Debt-to-Equity RatioN/A
Current Ratio10.95
Quick Ratio10.95

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$8.38 million
Price / Sales1.17
Cash Flow$0.1235 per share
Price / Cash Flow1.79
Book Value$0.21 per share
Price / Book1.05

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$5.44 million
Net Margins40.42%
Return on Equity-6.64%
Return on Assets-6.30%

Miscellaneous

Employees5
Outstanding Shares44,220,000
Market Cap$9.77 million
OptionableNot Optionable

Enzon Pharmaceuticals (OTCMKTS:ENZN) Frequently Asked Questions

What is Enzon Pharmaceuticals' stock symbol?

Enzon Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ENZN."

How were Enzon Pharmaceuticals' earnings last quarter?

Enzon Pharmaceuticals Inc (OTCMKTS:ENZN) released its earnings results on Wednesday, August, 10th. The biotechnology company reported $0.02 earnings per share for the quarter. The biotechnology company had revenue of $2.27 million for the quarter. Enzon Pharmaceuticals had a net margin of 40.42% and a negative return on equity of 6.64%. View Enzon Pharmaceuticals' Earnings History.

When is Enzon Pharmaceuticals' next earnings date?

Enzon Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Thursday, December 13th 2018. View Earnings Estimates for Enzon Pharmaceuticals.

Has Enzon Pharmaceuticals been receiving favorable news coverage?

Headlines about ENZN stock have trended positive recently, InfoTrie reports. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Enzon Pharmaceuticals earned a news impact score of 2.3 on InfoTrie's scale. They also gave news articles about the biotechnology company a news buzz of 3.0 out of 10, indicating that recent news coverage is unlikely to have an effect on the company's share price in the near term.

Who are some of Enzon Pharmaceuticals' key competitors?

Who are Enzon Pharmaceuticals' key executives?

Enzon Pharmaceuticals' management team includes the folowing people:
  • Mr. Andrew Rackear, CEO & Sec. (Age 64)
  • Mr. Richard L. Feinstein, VP of Fin. & CFO (Age 75)

How do I buy shares of Enzon Pharmaceuticals?

Shares of ENZN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Enzon Pharmaceuticals' stock price today?

One share of ENZN stock can currently be purchased for approximately $0.2210.

How big of a company is Enzon Pharmaceuticals?

Enzon Pharmaceuticals has a market capitalization of $9.77 million and generates $8.38 million in revenue each year. Enzon Pharmaceuticals employs 5 workers across the globe.

What is Enzon Pharmaceuticals' official website?

The official website for Enzon Pharmaceuticals is http://www.enzon.com.

How can I contact Enzon Pharmaceuticals?

Enzon Pharmaceuticals' mailing address is 20 Commerce Drive Suite 135, Cranford NJ, 07016. The biotechnology company can be reached via phone at 732-980-4500 or via email at [email protected]


MarketBeat Community Rating for Enzon Pharmaceuticals (OTCMKTS ENZN)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  64 (Vote Outperform)
Underperform Votes:  53 (Vote Underperform)
Total Votes:  117
MarketBeat's community ratings are surveys of what our community members think about Enzon Pharmaceuticals and other stocks. Vote "Outperform" if you believe ENZN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ENZN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/9/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel